Chargement en cours...

Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors

Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) represent the most common subtype of NETs. The incidence of all NETs, and specifically GEP NETs, has risen exponentially over the last three decades. Only within the past several years have these tumors been appropriately classified, allowing...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Adv Med Oncol
Auteurs principaux: Das, Satya, Dasari, Arvind
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8141991/
https://ncbi.nlm.nih.gov/pubmed/34093744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211018047
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!